Conakry

Ebola kills, but it may be immunizing others at the same time

HOMELAND SECURITY NEWS WIRE                                         Oct. 22, 2014

Two Ebola researchers suggest that as Ebola continues to spread in West Africa, it may be silently immunizing large numbers of people who never fall ill or infect others, yet become protected from future infection. If such immunity is confirmed, it would have significant ramifications on projections of how widespread the disease will be and could help determine strategies that health workers use to contain the disease, according to a letter published last week in The Lancet medical journal.   http://download.thelancet.com/flatcontentassets/pdfs/PIIS0140673614618390.pdf?id=aaadpDXSyNZVP5Qg76oKu

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

U.S. tightens Ebola monitoring for West African visitors

NEW YORK -- U.S. health officials imposed fresh constraints on Wednesday on people entering the country from three countries at the center of West Africa's Ebola epidemic, mandating that they report their temperature daily and stay in touch with health authorities.

U.S. Coast Guard Health Technician Nathan Wallenmeyer (L) and Customs Border Protection (CBP) Supervisor Sam Ko conduct prescreening measures on a passenger arriving from Sierra Leone at O’Hare International Airport's Terminal 5 in Chicago, in this handout picture taken October 16, 2014.

The move announced by the U.S. Centers for Disease Control and Prevention (CDC) marked the latest precautions put in place by the U.S. government to stop the spread of the virus, but stopped short of a ban on travelers from Liberia, Sierra Leone and Guinea as demanded by some lawmakers.

Problem, Solution, SitRep, or ?: 

EBOLA RESPONSE ROAD MAP SITUATION REPORT

 

                                                                            22, October, 2014

WHO's  new report says the number of confirmed,suspected and probable Ebola cases has reached 9936 with 4877 deaths confirmed.

See full Report and graphs

http://apps.who.int/iris/bitstream/10665/137091/1/roadmapsitrep22Oct2014_eng.pdf?ua=1

Problem, Solution, SitRep, or ?: 

Ebola Outbreak Erodes Recent Advances in West Africa

NEW YORK TIMES                                 Oct. 22, 2014

Problem, Solution, SitRep, or ?: 

Ebola Study Projects Spread of Virus on Overseas Flights

A study projects up to three Ebola-infected people could be on overseas flights each month from the three most-affected African countries. WSJ's Gautam Naik reports. Photo: Getty

CLICK HERE - The Lancet - Assessment of the potential for international dissemination of Ebola virus via commercial air travel during the 2014 west African outbreak

wsj.com - by Gautam Naik - Oct. 20, 2014

Up to three Ebola-infected people could embark on overseas flights every month from the three most-affected African countries, according to a new study that projected travel patterns based on infection rates and recent flight schedules.

The findings, published Monday in the journal Lancet, suggest that Ebola cases could be spread overseas by unwitting travelers from the worst-hit countries—Guinea, Liberia and Sierra Leone.

The World Health Organization has estimated that, by early December, there could be as many as 10,000 new cases a week in west Africa.

Problem, Solution, SitRep, or ?: 

Ebola vaccine trials could start in Africa in January

UPDATE: Drugmakers to join forces to make millions of Ebola vaccine doses

REUTERS                                                                     Oct 22, 2014

By Ben Hirschler

LONDON -- Leading drugmakers plan to work together to speed up the development of an Ebola vaccine and hope to produce millions of doses for use next year.

U.S. firm Johnson & Johnson said on Wednesday that it aims to produce at least 1 million doses of its two-step vaccine next year and has already discussed collaboration with Britain's GlaxoSmithKline, which is working on a rival vaccine.

The economics of an Ebola vaccine are still unclear but drug companies with an eye on their reputations are under pressure to respond to the major international health crisis now ravaging one of the poorest corners of Africa.

Problem, Solution, SitRep, or ?: 

Special Report - A Primer on Ebola for Clinicians

journals.cambridge.org -  Eric Toner, Amesh Adalja and Thomas Inglesby. A Primer on Ebola for Clinicians.
Disaster Medicine and Public Health Preparedness, available on CJO2014. doi:10.1017/dmp.2014.115.

Abstract

The size of the world’s largest Ebola outbreak now ongoing in West Africa makes clear that further exportation of Ebola virus disease to other parts of the world will remain a real possibility for the indefinite future. Clinicians outside of West Africa, particularly those who work in emergency medicine, critical care, infectious diseases, and infection control, should be familiar with the fundamentals of Ebola virus disease, including its diagnosis, treatment, and control. In this article we provide basic information on the Ebola virus and its epidemiology and microbiology. We also describe previous outbreaks and draw comparisons to the current outbreak with a focus on the public health measures that have controlled past outbreaks. We review the pathophysiology and clinical features of the disease, highlighting diagnosis, treatment, and hospital infection control issues that are relevant to practicing clinicians. We reference official guidance and point out where important uncertainty or controversy exists. (Disaster Med Public Health Preparedness. 2014;0:1-5)

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Review of Human-to-Human Transmission of Ebola Virus

CDC                                                              Posted Oct. 20, 2014 from  CDC  Oct. 17 document

This document is a concise summary of published information on the current science about human-to-human transmission of Ebola virus. It is developed for use by healthcare personnel and public health professionals to use. It is a complement to the many guidance documents that CDC has issued already online at

www.cdc.gov/ebola.

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

The Bigger Picture: Ebola - Dr. Michael D. McDonald

RT – Thom Hartmann - The Bigger Picture: Ebola – October 17-18, 2014

Dr. Michael D. McDonald, Robert Walker and DeAnn McEwen – A Discussion on Ebola

To stop Ebola from spreading in West Africa, Dr. Michael D. McDonald, Executive Director of Health Initiatives Foundation Inc. and the Global Resilience System talks about the need to have community strategies where we set up Resilience Capacity Zones to reduce the transmission and the translocation of Ebola. He states we need to create behavioral and social immunity around Ebola-affected areas to reduce the transmission and translocation. We need to create Ebola-resistant, and Ebola-free zones in ring-like fashion.

CLICK HERE - The Bigger Picture: Ebola

http://www.youtube.com/watch?v=FZlUp_aVgxc

Country / Region Tags: 
General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Long Quest for Ebola Vaccine Slowed by Science, Ethics, Politics

An experimental Ebola vaccine has been developed by the U.S. National Institutes of Health and pharmaceutical company GlaxoSmithKline. Photograph by Steve Parsons, AP

Image: An experimental Ebola vaccine has been developed by the U.S. National Institutes of Health and pharmaceutical company GlaxoSmithKline. Photograph by Steve Parsons, AP

news.nationalgeographic.com - October 14th, 2014 - Karen Weintraub

Ebola vaccines are so effective in monkeys that macaques can be protected or rescued even if they're injected with a hundred times the lethal dose of the Ebola virus after vaccination. But no one knows for certain whether the vaccines will work in humans; the vaccines haven't yet been rigorously tested in people.

Just developing the vaccines to test in monkeys was a grueling, decades-long process that has killed scores of macaques since the 1990s.

(VIEW COMPLETE ARTICLE)

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Conakry
howdy folks
Page loaded in 0.521 seconds.